Insider · CIK 0001540660

Bryan Jones W.

Reports to the SEC for 2 companies · ROCKVILLE, MD

sec.gov

Transactions

Companies

Filings

CIK

0001540660

Forms 4 and 5

Insider transactions

14 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-02-13	Sucampo Pharmaceuticals, Inc.D Disposition to Issuer	Sr. Vice Pres., BD & Licensing	DDisposition to Issuer	−5,139 sh	$18.00	−$92.5K	0
2018-02-13	Sucampo Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	Sr. Vice Pres., BD & Licensing	DDisposition to Issuer	−150K sh	$7.10	−$1.07M	0
2017-08-04	Sucampo Pharmaceuticals, Inc.P Purchase	Sr. Vice Pres., BD & Licensing	PPurchase	+4,700 sh	$10.60	+$49.8K	4,700
2015-03-30	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	VP of Business Development	MExercise/Conversion	+6,712 sh	$2.56	+$17.2K	74,692
2015-03-30	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	VP of Business Development	SSale	−6,712 sh	$12.02	−$80.6K	67,980
2015-03-30	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	VP of Business Development	MExercise/Conversion	−6,712 sh	—	—	30,763
2015-03-24	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	VP of Business Development	MExercise/Conversion	−25 sh	—	—	37,475
2015-03-24	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	VP of Business Development	MExercise/Conversion	+1,875 sh	$3.36	+$6,300	69,855
2015-03-24	SUPNSUPERNUS PHARMACEUTICALS, INC.M Exercise/Conversion	VP of Business Development	MExercise/Conversion	+25 sh	$2.56	+$64	69,880
2015-03-24	SUPNSUPERNUS PHARMACEUTICALS, INC.S Sale	VP of Business Development	SSale	−1,900 sh	$12.00	−$22.8K	67,980
2015-03-24	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)M Exercise/Conversion	VP of Business Development	MExercise/Conversion	−1,875 sh	—	—	625
2015-03-03	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)A Award	VP of Business Development	AAward	+25K sh	—	—	25,000
2014-01-21	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)A Award	VP of Business Development	AAward	+30K sh	—	—	30,000
2013-02-05	SUPNSUPERNUS PHARMACEUTICALS, INC. · Employee Stock Option (Right to Buy)A Award	VP of Business Development	AAward	+70K sh	—	—	70,000

Recent filings

Accepted (ET)
Feb 134
Bryan Jones W.0001171843-18-001101
SEC(opens sec.gov)
Aug 74
Bryan Jones W.0001171843-17-004784
SEC(opens sec.gov)
Mar 314
SUPERNUS PHARMACEUTICALS INC0001104659-15-024705
SEC(opens sec.gov)
Mar 264
SUPERNUS PHARMACEUTICALS INC0001104659-15-023152
SEC(opens sec.gov)
Mar 54
SUPERNUS PHARMACEUTICALS INC0001104659-15-016989
SEC(opens sec.gov)
Jan 234
SUPERNUS PHARMACEUTICALS INC0001104659-14-003886
SEC(opens sec.gov)
Feb 74
Bryan Jones W.0001181431-13-007794
SEC(opens sec.gov)

Companies

Address

C/O SUPERNUS PHARMACEUTICALS, INC. 1550 EAST GUDE DRIVE

ROCKVILLE, MD, 20850